Uvamin retard
Uvamin retard is a medicine authorised by Swissmedic under authorisation number 35941. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 15 March 1971 and the authorisation is valid without a time limit. ATC code J01XE01 places the medicine in the group Antibacterials for systemic use.
| Authorisation number | 35941 |
|---|---|
| Name | Uvamin retard |
| Full name | Uvamin retard, Kapseln |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | J01XE01 |
| First authorisation | 15 March 1971 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 2 | Uvamin retard, Kapseln | B | 16 December 1996 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 29 | 30 | Kapsel(n) | J01XE01 | 08.01.9. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Uvamin retard authorised in Switzerland?
Yes. Uvamin retard is authorised by Swissmedic under authorisation number 35941, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Uvamin retard have?
Uvamin retard is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Uvamin retard?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.